AOPs

OECD View API
Toggle for API info
The API endpoint defaults to 25 results per page, but you can adjust this by changing the per_page parameter in the URL.
Searches both title and fulltext content
Takes you to the requested AOP
Clear Search Terms Clears search terms and filters

Showing 76 to 100 of 476 AOPs

Clear Table Filters
ID Title Point of Contact License MIE AO OECD Status OECD Project
95 Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival Brendan Ferreri-Hanberry BY-SA 593: Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel 592: Reduced, survival 1.29
96 Axonal sodium channel modulation leading to acute mortality Arthur Author BY-SA 598: modulation, sodium channel 351: Increased Mortality 1.29
97 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline Agnes Aggy BY-SA 619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) 1.29
98 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation Allie Always BY-SA 619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) 588: Increased, predation 1.29
99 Histamine (H2) receptor antagonism leading to reduced survival Evgeniia Kazymova BY-SA 638: Antagonism, Histamine Receptor (H2) 1.29
100 Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior Cataia Ives BY-SA 79: Inhibition, Cyclooxygenase activity 1.29
101 Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release Brendan Ferreri-Hanberry BY-SA 79: Inhibition, Cyclooxygenase activity 1.29
102 Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition Arthur Author BY-SA 79: Inhibition, Cyclooxygenase activity 1.29
103 Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint Agnes Aggy BY-SA 79: Inhibition, Cyclooxygenase activity 1.29
104 Altered ion channel activity leading impaired heart function Allie Always BY-SA 697: impaired, ion channels 351: Increased Mortality 1.29
105 Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) Evgeniia Kazymova BY-SA 714: Increased, Binding of chemicals to 2u (serum) 713: Increase, Adenomas/carcinomas (renal tubular) 1.29
106 Chemical binding to tubulin in oocytes leading to aneuploid offspring Cataia Ives BY-SA 718: Binding, Tubulin 728: Increase, Aneuploid offspring Under Review 1.11
107 Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat Brendan Ferreri-Hanberry BY-SA 715: Activation, Constitutive androstane receptor 719: Increase, hepatocellular adenomas and carcinomas Under Review 1.17
108 Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat) Arthur Author BY-SA 724: Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme 719: Increase, hepatocellular adenomas and carcinomas 1.29
109 Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse) Agnes Aggy BY-SA 770: Increase, Cytotoxicity (club cells) 736: Increase, Adenomas/carcinomas (bronchioloalveolar) 1.29
110 Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse) Allie Always BY-SA 424: Inhibition, Na+/I- symporter (NIS) 741: Increase, Adenomas/carcinomas (follicular cell) 1.29
111 Decrease in androgen receptor activity leading to Leydig cell tumors (in rat) Evgeniia Kazymova BY-SA 742: Decreased, Androgen receptor activity 745: Increase, Leydig cell tumors 1.29
112 Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat) Cataia Ives BY-SA 746: Increase, Dopaminergic activity 773: Increase, Endometrial adenocarcinomas 1.29
113 Glutamate-gated chloride channel activation leading to acute mortality Brendan Ferreri-Hanberry BY-SA 760: Activation, Glutamate-gated chloride channel 1.29
114 HPPD inhibition leading to corneal papillomas and carcinomas (in rat) Arthur Author BY-SA 766: Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme 779: Increase, Papillomas/carcinomas (squamous cells) 1.29
115 Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat) Agnes Aggy BY-SA 780: Increase, Cytotoxicity (epithelial cells) 779: Increase, Papillomas/carcinomas (squamous cells) 1.29
116 Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) Allie Always BY-SA 783: Increase, Cytotoxicity (tubular epithelial cells) 713: Increase, Adenomas/carcinomas (renal tubular) 1.29
117 Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat) Evgeniia Kazymova Open for adoption 785: Activation, Androgen receptor 719: Increase, hepatocellular adenomas and carcinomas Under Development 1.26
118 Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat) Cataia Ives BY-SA 786: Increase, Cytotoxicity (hepatocytes) 719: Increase, hepatocellular adenomas and carcinomas 1.29
119 Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse) Brendan Ferreri-Hanberry BY-SA 279: Thyroperoxidase, Inhibition 741: Increase, Adenomas/carcinomas (follicular cell) 1.29